Towards personalized medicine: Utilizing biomarkers to track response of the inosine monophosphate dehydrogenase (IMPDH) inhibitor AVN944 patient samples from a Phase I clinical trial in AML and evaluation of a patient stratification signature.

作者
Jeffrey W. Strovel,J. Michael Hamilton,Tammy Lawrence,Marion Chakiath,Pachai Natarajan,Karina M. Zuck,Simon Katz,Stephen Glanowski,David K. Bol
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:13
摘要

A58 AVN944 is an orally bioavailable inhibitor of inosine monophosphate dehydrogenase 1 and 2 (IMPDH). IMPDH2 is highly up regulated and required for the de novo production of guanine nucleotides in many malignancies, including hematologic cancers. AVN944 has been in a repeat-dose, dose escalation trial in patients with advanced hematologic cancers including AML, CLL, Multiple Myeloma, and lymphomas. In addition to the objective of defining the maximum tolerated dose and repeat dose pharmacology of AVN944 (given bid for 21 days on a 28 day cycle), we have examined a comprehensive set of pharmacodynamic biomarkers. We have isolated peripheral blood samples from all patients in this trial both before and after receiving AVN944. These samples have been used to determine the effects of the drug on GTP pools and IMPDH enzyme activity, and to correlate these changes to the genetic response of the circulating cells using gene expression detection technologies. Examination of the behavior of these genes in patient samples from this phase I trial show a dynamic response of subsets of these genes depending on 1) the type of malignancy, 2) the predominant cell type in the peripheral blood, 3) the dose of AVN944 received, and 4) the number of treatment cycles completed. Perturbation of biomarkers in these samples relate directly to cellular pathways and functions dependent upon IMPDH activity and include guanine nucleotide biosynthesis, purine and pyrimidine biosynthesis, mitochondrial functions, metabolic pathways and energy production, cell proliferation and the apoptotic cascade. Increasing doses resulted in increases in the number of genes changing per individual, and/or an increase in the magnitude of change in a gene-dependent manner. These genetic markers, correlated with biochemical effects of the drug on protein function and guanine nucleotide levels, can be used as important biomarkers in selecting the optimal dose for additional studies with this drug and for enriching for patients most likely to respond to the drug.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
HAPPY完成签到,获得积分10
4秒前
桐桐的应助被Vincent采纳,获得10
5秒前
keleboys完成签到 ,获得积分10
7秒前
HMZ完成签到 ,获得积分10
9秒前
10秒前
HU完成签到 ,获得积分10
12秒前
13秒前
17秒前
小尾巴完成签到 ,获得积分10
20秒前
章鱼行者完成签到,获得积分10
20秒前
鲁文杰发布了新的文献求助10
21秒前
Maestro_S的应助被Vincent采纳,获得10
23秒前
24秒前
万能图书馆的应助被Vincent采纳,获得10
30秒前
30秒前
水静完成签到,获得积分10
31秒前
川川完成签到 ,获得积分10
35秒前
36秒前
科研通AI6.4的应助被Vincent采纳,获得10
36秒前
37秒前
标致访旋完成签到,获得积分10
38秒前
烂漫墨镜完成签到 ,获得积分10
41秒前
20230054发布了新的文献求助10
43秒前
43秒前
隐形曼青的应助被Vincent采纳,获得10
45秒前
鲁文杰完成签到,获得积分10
48秒前
48秒前
整齐百褶裙完成签到 ,获得积分10
53秒前
Changhiwi完成签到 ,获得积分10
54秒前
李健的小迷弟的应助被Vincent采纳,获得10
55秒前
55秒前
彳系禾完成签到 ,获得积分10
56秒前
Jzhaoc580完成签到 ,获得积分10
58秒前
冷艳凡灵完成签到,获得积分10
1分钟前
花果茶百道完成签到 ,获得积分10
1分钟前
1分钟前
一定长完成签到,获得积分10
1分钟前
华仔的应助被Vincent采纳,获得10
1分钟前
平静完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190366
求助须知:如何正确求助?哪些是违规求助? 9577437
关于积分的说明 21852521
捐赠科研通 7788988
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995